Publications by authors named "S Toriyama"

Claim this Profile
R
Remitting seronegative symmetrical synovitis with pitting edema syndrome in maintenance hemodialysis.
Toru Matsugasumi, Tsuneyuki Nakanouchi, Kazuya Mikami, Takumi Shiraishi, Masatoshi Kadoya, Seijiro Toriyama

IJU Case Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma.
Nobuhisa Hagiwara, Motoki Watanabe, Mahiro Iizuka-Ohashi, Isao Yokota, Seijiro Toriyama

Cancer Lett· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR inhibitor BGJ398 and HDAC inhibitor OBP-801 synergistically inhibit cell growth and induce apoptosis in bladder cancer cells.
Toshiya Takamura, Mano Horinaka, Shusuke Yasuda, Seijiro Toriyama, Yuichi Aono

Oncol Rep· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells.
Seijiro Toriyama, Mano Horinaka, Shusuke Yasuda, Tomoyuki Taniguchi, Yuichi Aono

Mol Cancer Ther· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer.
T Taniguchi, Y Iizumi, M Watanabe, M Masuda, M Morita, S Toriyama

Cell Death Dis· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis